Primary/congenital immunodeficiency

American Journal of Clinical Pathology

Volumn 147, Issue 2, 2017, Pages 204-216

  Gratzinger, Dita ^a   Jaffe, Elaine S ^b   Chadburn, Amy ^c   Chan, John K C ^d   De Jong, Daphne ^e   Goodlad, John R ^f   Said, Jonathan ^g   Natkunam, Yasodha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g UCLA MEDICAL CENTER   (United States)

Author keywords

Autoimmune lymphoproliferative syndrome; Common variable immunodeficiency; Double negative T cells; Primary immunodeficiency; T cell lymphoma

Indexed keywords

IMMUNOGLOBULIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOIMMUNITY; B LYMPHOCYTE; CELL EXPANSION; CHEDIAK HIGASHI SYNDROME; COMBINED IMMUNODEFICIENCY; COMBINED VARIABLE IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; CYTOTOXIC T LYMPHOCYTE; DIGEORGE SYNDROME; DISEASE PREDISPOSITION; DNA REPAIR; DOWN SYNDROME; GRANULOMATOSIS; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTE; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; OMENN SYNDROME; PRIORITY JOURNAL; RAS RELATED LEUKOPROLIFERATIVE DISORDER; REVIEW; SIGNAL TRANSDUCTION; SINUS HISTIOCYTOSIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VELOCARDIOFACIAL SYNDROME; WISKOTT ALDRICH SYNDROME; WORKSHOP; X LINKED LYMPHOPROLIFERATIVE DISORDER; COMPLICATION; EDUCATION; FEMALE; IMMUNOLOGY; LYMPHOPROLIFERATIVE DISORDERS; MALE; PATHOLOGY;

EDUCATION; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 85017482041     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1093/ajcp/aqw215     Document Type: Review

References (71)

1. Bousfiha A, Jeddane L, Al-Herz W, et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2015; 35: 727-738.
2. de Saint BG, Sepulveda FE, Maschalidi S, et al. Cytotoxic granule secretion by lymphocytes and its link to immune homeostasis. F1000Research. 2015. http://f1000research.com/ar ticles/4-930/v1. Accessed April 2, 2016.
3. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995; 81: 935-946.
4. Tarbox JA, Keppel MP, Topcagic N, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014; 34: 594-599.
5. Price S, Shaw PA, Seitz A, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014; 123: 1989-1999.
6. Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010; 116: e35-e40.
7. Lambotte O, Neven B, Galicier L, et al. Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults. Haematologica. 2013; 98: 389-392.
8. Lim MS, Straus SE, Dale JK, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998; 153: 1541-1550.
9. Maric I, Pittaluga S, Dale JK, et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol. 2005; 29: 903-911.
10. Venkataraman G, McClain KL, Pittaluga S, et al. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome (ALPS) and associated Rosai-Dorfman disease. Am J Surg Pathol. 2010; 34: 589-594.
11. Oliveira JB, Bidère N, Niemela JE, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 2007; 104: 8953-8958.
12. Takagi M, Shinoda K, Piao J, et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood. 2011; 117: 2887-2890.
13. Lanzarotti N, Bruneau J, Trinquand A, et al. RAS-Associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia. Blood. 2014; 123: 1960-1963.
14. Calvo KR, Price S, Braylan RC, et al. JMML and RALD (Ras-Associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015; 125: 2753-2758.
15. Dotta L, Parolini S, Prandini A, et al. Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis. 2013; 8: 168.
16. Bohn G, Allroth A, Brandes G, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med. 2007; 13: 38-45.
17. Law RHP, Lukoyanova N, Voskoboinik I, et al. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature. 2010; 468: 447-451.
18. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999; 286: 1957-1959.
19. Tesi B, Chiang SCC, El-Ghoneimy D, et al. Spectrum of atypical clinical presentations in patients with biallelic PRF1 missense mutations. Pediatr Blood Cancer. 2015; 62: 2094-2100.
20. Ciambotti B, Mussolin L, d Amore ESG, et al. Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma. J Pediatr Hematol Oncol. 2014; 36: e359-e365.
21. Nichols KE, Ma CS, Cannons JL, et al. Molecular and cellular pathogenesis of X-l inked lymphoproliferative disease. Immunol Rev. 2005; 203: 180-199.
22. Tangye SG. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. J Clin Immunol. 2014; 34: 772-779.
23. Wimmer K, Kratz CP, Vasen HFA, et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium care for CMMRD (C4CMMRD). J Med Genet. 2014; 51: 355-365.
24. Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program. 2012; 2012: 301-305.
25. Roskin KM, Simchoni N, Liu Y, et al. IgH sequences in common variable immune deficiency reveal altered B cell development and selection. Sci Transl Med. 2015; 7: 302ra135.
26. Ramesh M, Hamm D, Simchoni N, et al. Clonal and constricted T cell repertoire in common variable immune deficiency. Clin Immunol Orlando Fla. 2015; 61: 190-196.
27. Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol. 1990; 81: 357-367.
28. Lucas CL, Kuehn HS, Zhao F, et al. Dominant-Activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110d result in T cell senescence and human immunodeficiency. Nat Immunol. 2014; 15: 88-97.
29. Crank MC, Grossman JK, Moir S, et al. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J Clin Immunol. 2014; 34: 272-276.
30. Ochs HD, Smith CI. X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine (Baltimore). 1996; 75: 287-299.
31. Ramesh M, Simchoni N, Hamm D, et al. High-Throughput sequencing reveals an altered T cell repertoire in X-linked agammaglobulinemia. Clin Immunol Orlando Fla. 2015; 161: 190-196.
32. Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014; 34: 627-632.
33. de Villartay J-P, Lim A, Al-Mousa H, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005; 115: 3291-3299.
34. Ehl S, Schwarz K, Enders A, et al. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest. 2005; 115: 3140-3148.
35. Huang Y, Getahun A, Heiser RA, et al. cd T cells shape preimmune peripheral B cell populations. J Immunol Baltim Md 1950. 2016; 196: 217-231.
36. Schuetz C, Huck K, Gudowius S, et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med. 2008; 358: 2030-2038.
37. De Ravin SS, Cowen EW, Zarember KA, et al. Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood. 2010; 116: 1263-1271.
38. Walter JE, Rosen LB, Csomos K, et al. Broad-spectrum antibodies against self-Antigens and cytokines in RAG deficiency. J Clin Invest. 2015; 125: 4135-4148.
39. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994; 78: 635-644.
40. Kolhatkar NS, Brahmandam A, Thouvenel CD, et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med. 2015; 212: 1663-1677.
41. Metzler G, Kolhatkar NS, Rawlings DJ. BCR and co-receptor crosstalk facilitate the positive selection of self-reactive transitional B cells. Curr Opin Immunol. 2015; 37: 46-53.
42. Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009; 361: 2046-2055.
43. Randall KL, Lambe T, Johnson AL, et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat Immunol. 2009; 10: 1283-1291.
44. Lambe T, Crawford G, Johnson AL, et al. DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol. 2011; 41: 3423-3435.
45. Corneo B, Moshous D, Güngör T, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood. 2001; 97: 2772-2776.
46. Volk T, Pannicke U, Reisli I, et al. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency. Hum Mol Genet. 2015; 24: 7361-7372.
47. Lee YN, Frugoni F, Dobbs K, et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-Activating gene 1 deficiency. J Allergy Clin Immunol. 2014; 133: 1099-1108.e12.
48. Geier CB, Piller A, Linder A, et al. Leaky RAG deficiency in adult patients with impaired antibody production against bacterial polysaccharide antigens. PLoS One. 2015; 10: e0133220.
49. Gul KA, Øverland T, Osnes L, et al. Neonatal levels of Tcell receptor excision circles (TREC) in patients with 22q11.2 deletion syndrome and later disease features. J Clin Immunol. 2015; 35: 408-415.
50. Derfalvi B, Maurer K, McDonald McGinn DM, et al. B cell development in chromosome 22q11.2 deletion syndrome. Clin Immunol Orlando Fla. 2016; 163: 1-9.
51. Vissers LELM, van Ravenswaaij CMA, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004; 36: 955-957.
52. Wong MTY, Lambeck AJA, van der Burg M, et al. Immune dysfunction in children with CHARGE syndrome: a crosssectional study. PLoS One. 2015; 10: e0142350.
53. Lima FA, Moreira-Filho CA, Ramos PL, et al. Decreased AIRE expression and global thymic hypofunction in Down syndrome. J Immunol Baltim Md 1950. 2011; 187: 3422-3430.
54. Giménez-Barcons M, Casterás A, Armengol M. d P, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. J Immunol Baltim Md 1950. 2014; 193: 3872-3879.
55. Carsetti R, Valentini D, Marcellini V, et al. Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome. Eur J Immunol. 2015; 45: 903-914.
56. Van Krieken JH, Onciu M, Elenitoba-Johnson KS, et al. Lymphoproliferative diseases associated with primary immune disorders. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHOClassification of Tumours of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC; 2008: 336-339.
57. Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer-A study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010; 34: 405-417.
58. Swerdlow SH, Weber SA, Chadburn A, et al. Post-Transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC: 343-349.
59. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. 2016; 127: 2375-2390.
60. Völkl S, Rensing-Ehl A, Allg€auer A, et al. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome. Blood. 2016; 128: 227-238.
61. van den Berg A, Tamminga R, de Jong D, et al. FAS gene mutation in a case of autoimmune lymphoproliferative syndrome type IA with accumulation of gammadelta+ T cells. Am J Surg Pathol. 2003; 27: 546-553.
62. Viallard J-F, Blanco P, André M, et al. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol Orlando Fla. 2006; 119: 51-58.
63. Ziol M, Poirel H, Kountchou GN, et al. Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver. Hum Pathol. 2004; 35: 1241-1251.
64. Szablewski V, René C, Costes V. Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder. Virchows Arch Int J Pathol. 2015; 467: 733-740.
65. Gammon B, Robson A, Deonizio J, et al. CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency. J Am Acad Dermatol. 2014; 71: 555-560.
66. Lavoine N, Colas C, Muleris M, et al. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort. J Med Genet. 2015; 52: 770-778.
67. Suarez F, Mahlaoui N, Canioni D, et al. Incidence, presentation, and prognosis of malignancies in ataxia-Telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol off J Am Soc Clin Oncol. 2015; 33: 202-208.
68. Garand R, Goasguen J, Brizard A, et al. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d Hématologie Cellulaire. Br J Haematol. 1998; 103: 488-494.
69. Washington K, Stenzel TT, Buckley RH, et al. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996; 20: 1240-1252.
70. Malamut G, Verkarre V, Suarez F, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010; 105: 2262-2275.
71. Ganapathi KA, Townsley DM, Hsu AP, et al. GATA2 deficiency-Associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015; 125: 56-70.